TrialThe European respiratory journal2013
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma.
Edward Piper et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
131 papers cite itlatest 60 shown
this paperpooled ittrialcites it